Sun Pharma Selects Kirti Ganorkar As MD; Ascroft To Head North America Ops

Sun Pharmaceutical Industries Ltd. on Friday said its board has approved the appointment of Kirti Ganorkar as managing director for a five-year term, effective September 1. Ganorkar will take over from Dilip Shanghvi, who will continue as executive chairman of the board, the company said in an exchange filing.

Ganorkar currently heads Sun Pharma’s India business, a role he has held since June 2019. He has led several key verticals at the company, including business development, marketing, M&A, new product launches, project management, and intellectual property and litigation.

The company also announced that Richard Ascroft will take over as chief executive officer of Sun Pharma’s North America business, replacing Abhay Gandhi. The date of Ascroft’s appointment was not disclosed.